CLINICAL_TRIALS
trial_result
· 2011-02-24
Clinical Trial Update: Ondansetron Augmentation in Treatment-resistant OCD [Phase 4]
Summary
A Phase 4 study evaluating ondansetron augmentation in treatment-resistant obsessive-compulsive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Institute of Neuroscience, Florence, Italy | Conditions: Obsessive Compulsive Disorder | Phase 4 | Status: COMPLETED